Division of Vascular Surgery
Since its inception, the Division of Vascular Surgery and Endovascular Therapy of the Department of Surgery at Emory has had an international role in advancing the treatment of arterial and venous disease. In the early 1990s, vascular surgery in general and our division in particular began shifting focus from traditional, open procedures to minimally-invasive and endovascular therapy techniques. This transition was validated by a wide range of clinical trials undertaken by our board-certified faculty physicians, who became recognized as national leaders in training, research, and the performance of endovascular procedures.
Dr. William Jordan is the chief of the Division of Vascular Surgery. Dr. Jordan received his MD and completed his vascular surgery fellowship at Emory, at which point he joined the University of Alabama at Birmingham. He returned to Emory in 2016. His clinical and research interests encompass the minimally invasive treatment of aortic diseases, carotid artery diseases, and peripheral vascular diseases.
The division's clinical research program provides patients with the opportunity to benefit from progressive technology through numerous clinical trials. Projects in the basic science research laboratory primarily investigate the regenerative potential of ischemic tissue and test novel regenerative therapeutic approaches to tissue engineering as it relates to limb salvage and cardiovascular health.
The residency in vascular surgery and endovascular therapy at Emory was one of the first programs in the U.S. to provide advanced postgraduate training for the care of the patient with vascular disease. The two-year, ACGME-approved program emphasizes surgical and endovascular therapy for venous and arterial disease, vascular medicine, and vascular diagnostics.